Clinical Trial Update: Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

View source ↗

Summary

MiraKind sponsors a clinical trial to validate the role of microRNA binding site mutations in cancer risk, prevention, and treatment, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: MiraKind | Conditions: Cancer | Status: RECRUITING